Search Results - "Fimbo, Adam"

Lessons from enriching Tanzania's clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project.

Authors: Fimbo, Adam Mwalwisi, Yona H. Matiko, Damas et al.

Source: Discover Public Health. 8/12/2024, Vol. 21 Issue 1, p1-7. 7p.

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.

Authors: Fimbo, Adam M. Mnkugwe, Rajabu Hussein Mlugu, Eulambius Mathias et al.

Source: Infectious Diseases of Poverty. 6/12/2024, Vol. 13 Issue 1, p1-13. 13p.

Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania.

Authors: Fimbo, Adam Mwalwisi, Yonah H. Mwamwitwa, Kissa et al.

Source: Scientific Reports. 1/5/2024, Vol. 14 Issue 1, p1-10. 10p.

Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania.

Authors: Fimbo, Adam M. Mlugu, Eulambius M. Kitabi, Eliford Ngaimisi et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Dec2023, Vol. 12 Issue 12, p1884-1896. 13p.

Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania.

Authors: Mwamwitwa, Kissa W. Fimbo, Adam M. Bukundi, Elias M. et al.

Source: Scientific Reports. 9/27/2022, Vol. 12 Issue 1, p1-11. 11p.

Post marketing surveillance of selected veterinary medicines in Tanzania mainland.

Authors: Fimbo, Adam M. Maganda, Betty A. Mwamwitwa, Kissa W. et al.

Source: BMC Veterinary Research. 6/9/2022, Vol. 18 Issue 1, p1-8. 8p.

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study.

Authors: Fimbo, Adam M. Minzi, Omary Mashiku Mmbando, Bruno P. et al.

Source: Pharmaceuticals (14248247). May2022, Vol. 15 Issue 5, p594-594. 13p.

Adverse Drug Reactions Resulting From the Use of Chiral Medicines Amoxicillin, Amoxicillin-Clavulanic Acid, and Ceftriaxone: A Mixed Prospective-Retrospective Cohort Study.

Authors: Mwamwitwa, Kissa W. Bukundi, Elias M. Maganda, Betty A. et al.

Source: Inquiry (00469580); 9/15/2024, p1-18, 18p

The comparison of the quality of selected brands of antibiotics in Tanzania sourced from different geographical regions.

Authors: Mwalwisi, Yonah Hebron Fimbo, Adam Mitangu Hoellein, Ludwig et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Jul2024, Vol. 79 Issue 7, p1619-1627. 9p.

Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania.

Authors: Fimbo, Adam M. Minzi, Omary M.S. Mmbando, Bruno P. et al.

Source: Journal of Clinical Medicine. May2020, Vol. 9 Issue 5, p1550-1550. 1p.

Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania.

Authors: Mssusa, Alambo Fimbo, Adam Nkayamba, Alex et al.

Source: Clinical Drug Investigation. May2016, Vol. 36 Issue 5, p401-411. 11p. 5 Charts, 1 Graph.

A retrospective cross-sectional study to determine chirality status of registered medicines in Tanzania.

Authors: Mwamwitwa, Kissa W. Kaibere, Raphael M. Fimbo, Adam M. et al.

Source: Scientific Reports. 10/20/2020, Vol. 10 Issue 1, p1-11. 11p.

Optimizing the East African Community's Medicines Regulatory Harmonization initiative in 2020-2022: A Roadmap for the Future.

Authors: Arik, Mawien Bamenyekanye, Emmanuel Fimbo, Adam et al.

Source: PLoS Medicine. 8/12/2020, Vol. 17 Issue 8, p1-11. 11p. 2 Charts.

Good manufacturing practice inspections conducted by Tanzania medicines and medical devices authority: a comparative study of two fiscal years from 2018 to 2020.

Authors: Sangeda, Raphael Zozimus Ndabatinya, Chimpaye Julius Maganga, Maganga Bundala et al.

Source: Journal of Pharmaceutical Policy & Practice. Dec2024, Vol. 17 Issue 1, p1-19. 19p.

A high-performance thin-layer chromatography densitometric method for the separation of isomeric ceftriaxone in powder for injection formulation.

Authors: Mwamwitwa, Kissa W. Nyamweru, Bugusu Iwodyah, Mohamed A. et al.

Source: Scientific Reports. 11/1/2024, Vol. 14 Issue 1, p1-9. 9p.

Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative: Proposed Revised EAC-MRH Review Model: N. Ngum et al.

Authors: Ngum, Nancy Chamdimba, Chimwemwe Mbonyingingo, Dedith et al.

Source: Pharmaceutical Medicine. Mar2025, Vol. 39 Issue 2, p125-141. 17p.

Short-Term Training, a Useful Approach for Sustainable Pharmacovigilance Knowledge Development in Tanzania, Kenya, Ethiopia and Rwanda.

Authors: van Puijenbroek, Eugène Barry, Abbie Khaemba, Christabel et al.

Source: Drug Safety. Dec2024, Vol. 47 Issue 12, p1193-1202. 10p.

Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.

Authors: Mashingia, Jane H. Ahonkhai, Vincent Aineplan, Noel et al.

Source: PLoS Medicine. 8/12/2020, Vol. 17 Issue 8, p1-13. 13p. 2 Diagrams, 2 Graphs.

Benchmarking Pre-National Action Plan Systemic Antimicrobial Consumption in Tanzania, 1998-2005: A Historical Longitudinal Defined Daily Dose Analysis.

Authors: Sangeda RZ Kadinde AW Khea A et al.

Source: Cureus [Cureus] 2025 Dec 08; Vol. 17 (12), pp. e98729. Date of Electronic Publication: 2025 Dec 08 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE

Training Needs Assessment and Capacity Building of Clinical Trial Assessors and Ethical Reviewers to Strengthen Regulatory Review in Tanzania.

Authors: Mwamwitwa KW Munishi CG Makoye PM et al.

Source: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2026 Jul; Vol. 60 (4), pp. 1135-1143. Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE